{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:24:12Z","timestamp":1779344652648,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T00:00:00Z","timestamp":1765670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T00:00:00Z","timestamp":1767830400000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Ministry of Health, Labor, and Welfare, Japan","award":["23HC1001"],"award-info":[{"award-number":["23HC1001"]}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"crossref","award":["23K16527"],"award-info":[{"award-number":["23K16527"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-30591-4","type":"journal-article","created":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T18:24:46Z","timestamp":1765736686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Elevated liver enzyme trajectories in early adulthood and persistently high levels predict type 2 diabetes risk in Japanese adults"],"prefix":"10.1038","volume":"16","author":[{"given":"Kota","family":"Fukai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Nakazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kei","family":"Sano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Furuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Honda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Korenaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Tatemichi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,14]]},"reference":[{"key":"30591_CR1","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1111\/jgh.13264","volume":"31","author":"S Ballestri","year":"2016","unstructured":"Ballestri, S. et al. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis. J. Gastroenterol. Hepatol. 31, 936\u2013944. https:\/\/doi.org\/10.1111\/jgh.13264 (2016).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"30591_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1093\/aje\/kws469","volume":"178","author":"SK Kunutsor","year":"2013","unstructured":"Kunutsor, S. K., Apekey, T. A. & Walley, J. Liver aminotransferases and risk of incident type 2 diabetes: A systematic review and meta-analysis. Am. J. Epidemiol. 178, 159\u2013171. https:\/\/doi.org\/10.1093\/aje\/kws469 (2013).","journal-title":"Am. J. Epidemiol."},{"key":"30591_CR3","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/nrendo.2011.72","volume":"7","author":"BW Smith","year":"2011","unstructured":"Smith, B. W. & Adams, L. A. Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nat. Rev. Endocrinol. 7, 456\u2013465. https:\/\/doi.org\/10.1038\/nrendo.2011.72 (2011).","journal-title":"Nat. Rev. Endocrinol."},{"key":"30591_CR4","doi-asserted-by":"publisher","first-page":"4753","DOI":"10.1210\/jc.2006-0587","volume":"91","author":"KM Utzschneider","year":"2006","unstructured":"Utzschneider, K. M., Kahn, S. E. & Review The role of insulin resistance in nonalcoholic fatty liver disease. J. Clin. Endocrinol. Metab. 91, 4753\u20134761. https:\/\/doi.org\/10.1210\/jc.2006-0587 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"30591_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1872-034X.2012.01031.x","volume":"43","author":"P Loria","year":"2013","unstructured":"Loria, P., Lonardo, A. & Anania, F. Liver and diabetes. A vicious circle. Hepatol. Res. 43, 51\u201364. https:\/\/doi.org\/10.1111\/j.1872-034X.2012.01031.x (2013).","journal-title":"Hepatol. Res."},{"key":"30591_CR6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.cmet.2018.08.010","volume":"28","author":"R Taylor","year":"2018","unstructured":"Taylor, R. et al. Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for \u03b2 cell recovery. Cell. Metab. 28, 667. https:\/\/doi.org\/10.1016\/j.cmet.2018.08.010 (2018).","journal-title":"Cell. Metab."},{"key":"30591_CR7","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.2337\/db18-1048","volume":"68","author":"NMG De Silva","year":"2019","unstructured":"De Silva, N. M. G. et al. Liver function and risk of type 2 diabetes: bidirectional Mendelian randomization study. Diabetes 68, 1681\u20131691. https:\/\/doi.org\/10.2337\/db18-1048 (2019).","journal-title":"Diabetes"},{"key":"30591_CR8","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1503\/cmaj.1040752","volume":"172","author":"EG Giannini","year":"2005","unstructured":"Giannini, E. G., Testa, R. & Savarino, V. Liver enzyme alteration: a guide for clinicians. CMAJ 172, 367\u2013379. https:\/\/doi.org\/10.1503\/cmaj.1040752 (2005).","journal-title":"CMAJ"},{"key":"30591_CR9","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3389\/fmed.2020.00448","volume":"7","author":"F Idalsoaga","year":"2020","unstructured":"Idalsoaga, F., Kulkarni, A. V., Mousa, O. Y., Arrese, M. & Arab, J. P. Non-alcoholic fatty liver disease and alcohol-related liver disease: two intertwined entities. Front. Med. (Lausanne). 7, 448. https:\/\/doi.org\/10.3389\/fmed.2020.00448 (2020).","journal-title":"Front. Med. (Lausanne)"},{"key":"30591_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1161\/01.ATV.0000251993.20372.40","volume":"27","author":"DS Lee","year":"2007","unstructured":"Lee, D. S. et al. Gamma Glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham heart study. Arterioscler. Thromb. Vasc Biol. 27, 127\u2013133. https:\/\/doi.org\/10.1161\/01.ATV.0000251993.20372.40 (2007).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"30591_CR11","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78, 1966\u20131986. https:\/\/doi.org\/10.1097\/HEP.0000000000000520 (2023).","journal-title":"Hepatology"},{"key":"30591_CR12","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes, C. et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, united Kingdom, and united States for the period 2016\u20132030. J. Hepatol. 69, 896\u2013904. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.036 (2018).","journal-title":"J. Hepatol."},{"key":"30591_CR13","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.2337\/diacare.28.12.2913","volume":"28","author":"SG Wannamethee","year":"2005","unstructured":"Wannamethee, S. G., Shaper, A. G., Lennon, L. & Whincup, P. H. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care. 28, 2913\u20132918. https:\/\/doi.org\/10.2337\/diacare.28.12.2913 (2005).","journal-title":"Diabetes Care"},{"key":"30591_CR14","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.2337\/dc11-0919","volume":"34","author":"QM Nguyen","year":"2011","unstructured":"Nguyen, Q. M. et al. Elevated liver function enzymes are related to the development of prediabetes and type 2 diabetes in younger adults: the Bogalusa heart study. Diabetes Care. 34, 2603\u20132607. https:\/\/doi.org\/10.2337\/dc11-0919 (2011).","journal-title":"Diabetes Care"},{"key":"30591_CR15","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/jama.2013.285122","volume":"311","author":"NB Allen","year":"2014","unstructured":"Allen, N. B. et al. Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age. JAMA 311, 490\u2013497. https:\/\/doi.org\/10.1001\/jama.2013.285122 (2014).","journal-title":"JAMA"},{"key":"30591_CR16","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1002\/oby.23550","volume":"30","author":"M Hoyt","year":"2022","unstructured":"Hoyt, M., Song, Y., Gao, S., O\u2019Palka, J. & Zhang, J. Prediagnostic BMI trajectories in relation to pancreatic cancer risk in the Prostate, Lung, Colorectal, and ovarian cancer screening trial. Obes. (Silver Spring). 30, 2275\u20132285. https:\/\/doi.org\/10.1002\/oby.23550 (2022).","journal-title":"Obes. (Silver Spring)"},{"key":"30591_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.2337\/dc09-1197","volume":"33","author":"S Yamamoto","year":"2010","unstructured":"Yamamoto, S. et al. Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia. Diabetes Care. 33, 184\u2013189. https:\/\/doi.org\/10.2337\/dc09-1197 (2010).","journal-title":"Diabetes Care"},{"key":"30591_CR18","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/oby.2010.237","volume":"19","author":"Y Matsushita","year":"2011","unstructured":"Matsushita, Y. et al. Associations of smoking cessation with visceral fat area and prevalence of metabolic syndrome in men: the Hitachi health study. Obes. (Silver Spring). 19, 647\u2013651. https:\/\/doi.org\/10.1038\/oby.2010.237 (2011).","journal-title":"Obes. (Silver Spring)"},{"key":"30591_CR19","doi-asserted-by":"publisher","first-page":"1106831","DOI":"10.3389\/fpubh.2023.1106831","volume":"11","author":"K Kasuya","year":"2023","unstructured":"Kasuya, K. et al. Basic assessment on adding platelet measurement to legal health checkup in japan: A cross-sectional and 20-year longitudinal study. Front. Public. Health. 11, 1106831. https:\/\/doi.org\/10.3389\/fpubh.2023.1106831 (2023).","journal-title":"Front. Public. Health"},{"key":"30591_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40001-022-00976-6","volume":"28","author":"H Shinoda","year":"2023","unstructured":"Shinoda, H. et al. Significance of Fib4 index as an indicator of alcoholic hepatotoxicity in health examinations among Japanese male workers: a cross-sectional and retrospectively longitudinal study. Eur. J. Med. Res. 28, 31. https:\/\/doi.org\/10.1186\/s40001-022-00976-6 (2023).","journal-title":"Eur. J. Med. Res."},{"key":"30591_CR21","doi-asserted-by":"publisher","first-page":"e0262404","DOI":"10.1371\/journal.pone.0262404","volume":"17","author":"Y Watanabe","year":"2022","unstructured":"Watanabe, Y. et al. Descriptive study of chest x-ray examination in mandatory annual health examinations at the workplace in Japan. PLoS One. 17, e0262404. https:\/\/doi.org\/10.1371\/journal.pone.0262404 (2022).","journal-title":"PLoS One"},{"key":"30591_CR22","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.2040-1124.2012.00207.x","volume":"3","author":"A Kashiwagi","year":"2012","unstructured":"Kashiwagi, A. et al. International clinical harmonization of glycated hemoglobin in japan: from Japan diabetes society to National glycohemoglobin standardization program values. J. Diabetes Investig. 3, 39\u201340. https:\/\/doi.org\/10.1111\/j.2040-1124.2012.00207.x (2012).","journal-title":"J. Diabetes Investig"},{"key":"30591_CR23","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.2337\/dc14-S081","volume":"37","author":"American Diabetes Association","year":"2014","unstructured":"American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 37, S81\u2013S90. https:\/\/doi.org\/10.2337\/dc14-S081 (2014).","journal-title":"Diabetes Care"},{"key":"30591_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","volume":"6","author":"DS Nagin","year":"2010","unstructured":"Nagin, D. S. & Odgers, C. L. Group-based trajectory modeling in clinical research. Annu. Rev. Clin. Psychol. 6, 109\u2013138. https:\/\/doi.org\/10.1146\/annurev.clinpsy.121208.131413 (2010).","journal-title":"Annu. Rev. Clin. Psychol."},{"key":"30591_CR25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1007\/s10940-010-9113-7","volume":"26","author":"DS Nagin","year":"2010","unstructured":"Nagin, D. S. & Odgers, C. L. Group-based trajectory modeling (nearly) two decades later. J. Quant. Criminol. 26, 445\u2013453. https:\/\/doi.org\/10.1007\/s10940-010-9113-7 (2010).","journal-title":"J. Quant. Criminol."},{"key":"30591_CR26","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1177\/0049124101029003005","volume":"29","author":"BL Jones","year":"2001","unstructured":"Jones, B. L., Nagin, D. S. & Roeder, K. A SAS procedure based on mixture models for estimating developmental trajectories. Sociol. Methods Res. 29, 374\u2013393. https:\/\/doi.org\/10.1177\/0049124101029003005 (2001).","journal-title":"Sociol. Methods Res."},{"key":"30591_CR27","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.2147\/CLEP.S265287","volume":"12","author":"HL Nguena Nguefack","year":"2020","unstructured":"Nguena Nguefack, H. L. et al. Trajectory modelling techniques useful to epidemiological research: a comparative narrative review of approaches. Clin. Epidemiol. 12, 1205\u20131222. https:\/\/doi.org\/10.2147\/CLEP.S265287 (2020).","journal-title":"Clin. Epidemiol."},{"key":"30591_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s40471-020-00242-5","volume":"7","author":"E Hetherington","year":"2020","unstructured":"Hetherington, E., Plamondon, A. & Williamson, T. Trajectory modeling with latent groups: potentials and pitfalls. Curr. Epidemiol. Rep. 7, 171\u2013178. https:\/\/doi.org\/10.1007\/s40471-020-00242-5 (2020).","journal-title":"Curr. Epidemiol. Rep."},{"key":"30591_CR29","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","volume":"77","author":"ME Rinella","year":"2023","unstructured":"Rinella, M. E. et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77, 1797\u20131835. https:\/\/doi.org\/10.1097\/HEP.0000000000000323 (2023).","journal-title":"Hepatology"},{"key":"30591_CR30","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.14309\/ajg.0000000000000388","volume":"114","author":"S Gawrieh","year":"2019","unstructured":"Gawrieh, S. et al. Histologic findings of advanced fibrosis and cirrhosis in patients with nonalcoholic fatty liver disease who have normal aminotransferase levels. Am. J. Gastroenterol. 114, 1626\u20131635. https:\/\/doi.org\/10.14309\/ajg.0000000000000388 (2019).","journal-title":"Am. J. Gastroenterol."},{"key":"30591_CR31","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00535-012-0704-y","volume":"48","author":"M Yoneda","year":"2013","unstructured":"Yoneda, M. et al. Noninvasive scoring systems in patients with nonalcoholic fatty liver disease with normal Alanine aminotransferase levels. J. Gastroenterol. 48, 1051\u20131060. https:\/\/doi.org\/10.1007\/s00535-012-0704-y (2013).","journal-title":"J. Gastroenterol."},{"key":"30591_CR32","doi-asserted-by":"publisher","first-page":"101280","DOI":"10.1016\/j.aohep.2023.101280","volume":"29","author":"J Lee","year":"2024","unstructured":"Lee, J. et al. Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFT. Ann. Hepatol. 29, 101280. https:\/\/doi.org\/10.1016\/j.aohep.2023.101280 (2024).","journal-title":"Ann. Hepatol."},{"key":"30591_CR33","doi-asserted-by":"publisher","first-page":"e13110","DOI":"10.1002\/jgh3.13110","volume":"8","author":"T Miwa","year":"2024","unstructured":"Miwa, T. et al. Usefulness of health checkup-based indices in identifying metabolic dysfunction-associated steatotic liver disease. JGH Open. 8, e13110. https:\/\/doi.org\/10.1002\/jgh3.13110 (2024).","journal-title":"JGH Open."},{"key":"30591_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MEG.0000000000000233","volume":"27","author":"S Radcke","year":"2015","unstructured":"Radcke, S., Dillon, J. F. & Murray, A. L. A systematic review of the prevalence of mildly abnormal liver function tests and associated health outcomes. Eur. J. Gastroenterol. Hepatol. 27, 1\u20137. https:\/\/doi.org\/10.1097\/MEG.0000000000000233 (2015).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"30591_CR35","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.coph.2020.10.016","volume":"55","author":"S Guerra","year":"2020","unstructured":"Guerra, S. & Gastaldelli, A. The role of the liver in the modulation of glucose and insulin in Non alcoholic fatty liver disease and type 2 diabetes. Curr. Opin. Pharmacol. 55, 165\u2013174. https:\/\/doi.org\/10.1016\/j.coph.2020.10.016 (2020).","journal-title":"Curr. Opin. Pharmacol."},{"key":"30591_CR36","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1161\/ATVBAHA.114.303034","volume":"34","author":"CD Byrne","year":"2014","unstructured":"Byrne, C. D. & Targher, G. Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease. Arterioscler. Thromb. Vasc Biol. 34, 1155\u20131161. https:\/\/doi.org\/10.1161\/ATVBAHA.114.303034 (2014).","journal-title":"Arterioscler. Thromb. Vasc Biol."},{"key":"30591_CR37","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/dom.14651","volume":"24","author":"B Cariou","year":"2022","unstructured":"Cariou, B. The metabolic triad of non-alcoholic fatty liver disease, visceral adiposity and type 2 diabetes: implications for treatment. Diabetes Obes. Metab. 24, 15\u201327. https:\/\/doi.org\/10.1111\/dom.14651 (2022).","journal-title":"Diabetes Obes. Metab."},{"key":"30591_CR38","doi-asserted-by":"publisher","first-page":"e12138","DOI":"10.1002\/1348-9585.12138","volume":"62","author":"K Fukai","year":"2020","unstructured":"Fukai, K. et al. Validation of self-reported medication use for hypertension, diabetes, and dyslipidemia among employees of large-sized companies in Japan. J. Occup. Health. 62, e12138. https:\/\/doi.org\/10.1002\/1348-9585.12138 (2020).","journal-title":"J. Occup. Health"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30591-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30591-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30591-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T18:02:15Z","timestamp":1768154535000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-30591-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,14]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["30591"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-30591-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,14]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1075"}}